ADMA Biologics, Inc

(NASDAQ:ADMA)

Latest On ADMA Biologics, Inc (ADMA):

Date/Time Type Description Signal Details
2023-05-11 01:31 ESTNewsADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59MN/A
2023-05-11 01:30 ESTNewsADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 23:31 ESTNewsADMA Biologics Q1 2023 Earnings PreviewN/A
2023-03-30 00:16 ESTNewsADMA Biologics: Growth Trends Pointing To ProfitabilityN/A
2023-03-24 06:16 ESTNewsADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88MN/A
2023-03-24 06:16 ESTNewsADMA Biologics expects first-time positive EBITDA by second half of yearN/A
2023-03-24 06:15 ESTNewsADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 23:00 ESTNewsADMA Biologics Q4 2022 Earnings PreviewN/A
2023-02-08 18:02 ESTNewsADMA Biocenters receives FDA approval for eighth plasma collection centerN/A
2023-01-17 17:02 ESTNewsADMA Biologics gains as guidance exceeds consensusN/A
2023-01-15 06:00 ESTNewsADMA Biologics: FY22 Numbers Key Inflection PointN/A
2022-12-13 19:01 ESTNewsAdma gets FDA approval for room temperature storage of Asceniv, BivigamN/A
2022-12-08 03:17 ESTNewsADMA Biologics stock dips after pricing ~$60M share offeringN/A
2022-12-07 07:16 ESTNewsADMA Biologics down 7% following stock offeringN/A
2022-11-11 05:31 ESTNewsADMA Biologics hits 52-week high after strong Q3 beatN/A
2022-11-09 19:31 ESTNewsADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61MN/A
2022-11-09 19:30 ESTNewsADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 01:31 ESTNewsADMA Biologics Q3 2022 Earnings PreviewN/A
2022-10-31 13:46 ESTNewsAdma stock rises on FDA approval of North Carolina-based plasma collection centerN/A
2022-10-24 18:01 ESTNewsAdma Biologics: Understanding The Risks Of Blood Plasma CollectionN/A
2022-08-22 16:50 ESTNewsADMA Biologics: Strong Growth Is Clearing The Path To ProfitabilityN/A
2022-08-11 22:17 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 22:16 ESTNewsAdma stock rises 10% after Q2 revenue nearly doubles, net loss narrowsN/A
2022-08-11 05:31 ESTNewsADMA Biologics GAAP EPS of -$0.07, revenue of $33.9MN/A
2022-08-11 05:30 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 17:45 ESTNewsADMA Biologics Q2 2022 Earnings PreviewN/A
2022-06-27 23:02 ESTNewsADMA's 6th plasma collection facility gets FDA approvalN/A
2022-06-21 22:02 ESTNewsADMA biologics to enter Russell 2000 indexN/A
2022-05-13 06:31 ESTNewsADMA Biologics: A Path To Profits Looks ClearN/A
2022-05-12 11:47 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 18:00 ESTNewsADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95MN/A
2022-05-11 18:00 ESTNewsADMA Biologics up 4% after increasing 2022 revenue guidanceN/A
2022-05-10 22:45 ESTNewsADMA Biologics Q1 2022 Earnings PreviewN/A
2022-04-19 02:16 ESTNewsADMA: Pertinent UpdatesN/A
2022-04-04 13:21 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 21:17 ESTNewsADMA Biologics' 2021 Numbers Showed Continued Strong ExecutionN/A
2022-03-25 12:19 ESTNewsADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61MN/A
2022-03-25 12:19 ESTNewsADMA Biologics up in after-hours trading following quarterly top and bottom line beatsN/A
2022-03-25 12:18 ESTNewsADMA Biologics gets FDA approval to extend shelf life of Asceniv, BivigamN/A
2022-03-24 02:33 ESTNewsADMA Biologics Q4 2021 Earnings PreviewN/A
2022-02-10 22:16 ESTNewsAdma Biologics activist said to support strategic reviewN/A
2022-01-19 08:15 ESTNewsADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensusN/A
2022-01-18 16:46 ESTNewsADMA Biologics wins FDA nod for its fourth plasma collection centerN/A
2022-01-18 16:46 ESTNewsADMA Biologics: 2021 Was ToughN/A
2021-12-28 22:16 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-12-09 15:17 ESTNewsADMA Biologics secures new European patent related to S. pneumonia infectionsN/A
2021-11-20 23:16 ESTNewsADMA Biologics: Turning A CornerN/A
2021-11-11 20:31 ESTNewsADMA Biologics raised to Strong Buy at Raymond James citing financial momentumN/A
2021-11-11 00:15 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 01:31 ESTNewsADMA Biologics Q3 2021 Earnings PreviewN/A

About ADMA Biologics, Inc (ADMA):

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

See Advanced Chart

General

  • Name ADMA Biologics, Inc
  • Symbol ADMA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 313
  • Fiscal Year EndDecember
  • IPO Date2013-10-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.admabiologics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.32
  • Price/Book (Most Recent Quarter) 3.7
  • Enterprise Value Revenue 7.55
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.17
  • Profit Margin -166%
  • Operating Margin -138%
  • Return on Assets -21%
  • Return on Equity -124%
  • Revenue 40.3 million
  • Earnings Per Share -$1.24
  • Revenue Per Share $0.53
  • Gross Profit -10155155
  • Quarterly Earnings Growth 42.3%
View More

Highlights

  • Market Capitalization 195.71 million
  • EBITDA -52103768
  • Analyst Target Price $8.83
  • Book Value Per Share $0.80
View More

Share Statistics

  • Shares Outstanding 94.55 million
  • Shares Float 76.07 million
  • % Held by Insiders 213%
  • % Held by Institutions 54.51%
  • Shares Short 8.18 million
  • Shares Short Prior Month 8.75 million
  • Short Ratio 1.91
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.7
  • 52 Week High $4.2
  • 52 Week Low $1.73
  • 50 Day Moving Average 2.42
  • 200 Day Moving Average 2.23
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ADMA Biologics, Inc (ADMA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ADMA Biologics, Inc (ADMA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.19-$0.204.04%
2020-06-302020-08-05$N/A-$0.23-$0.16-42.24%
2020-03-312020-05-06$N/A-$0.26-$0.11-128.07%
2019-12-312020-03-12$12.04 million-$0.18-$0.18-0.95%
2019-09-302019-11-06$7.22 million-$0.19-$0.2315.56%
2019-06-302019-08-08$6.56 million-$0.25-$0.2914.65%
2019-03-312019-05-08$3.53 million-$0.28-$0.3211.39%
2018-12-312019-03-13$4.06 million-$0.39-$0.33-17.15%
2018-09-302018-11-08$4.23 million-$0.33-$0.31-6.45%
2018-06-302018-08-10$4.66 million-$0.35-$0.31-11.86%
2018-03-312018-05-14$4.04 million-$0.39-$0.31-26.83%
2017-12-312018-03-05$12 million-$0.24-$0.3938.46%
2017-09-302017-11-03$4.73 million-$0.59-$0.50-18.59%
2017-06-302017-08-11$3.4 million-$0.55-$0.30-84.87%
2017-03-312017-05-12$2.63 million-$0.51-$0.28-80.53%
2016-12-312017-02-24$3.33 million-$0.34-$0.32-5.59%
2016-09-302016-11-10$2.94 million-$0.34-$0.4117.87%
2016-06-302016-08-12$2.27 million-$0.50-$0.38-30.89%
2016-03-312016-05-13$2.12 million-$0.43-$0.442.82%
2015-12-312016-03-23$2.51 million-$0.44-$0.452.22%
2015-09-302015-11-10$1.85 million-$0.48-$0.39-23.08%
2015-06-302015-08-11$1.31 million-$0.44-$0.35-25.71%
2015-03-312015-05-12$1.5 million-$0.37-$0.382.63%
2014-12-312015-03-09$1.49 million-$0.38-$0.380%
2014-09-302014-11-10$1.37 million-$0.36-$0.372.7%
2014-06-302014-08-11$1.5 million-$0.43-$0.5217.31%
2014-03-312014-05-12$1.56 million-$0.64-$0.49-30.61%
2013-12-312014-03-28$425000-$0.54-$0.47-14.89%
2013-09-302013-11-12$1.11 million-$0.29

ADMA Biologics, Inc (ADMA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ADMA Biologics, Inc (ADMA) Chart:

ADMA Biologics, Inc (ADMA) News:

Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ADMA Biologics, Inc (ADMA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-17511.98CALL0 8374.52TRUE00
2026-04-1780CALL0 0222.58TRUE00
2026-04-1798.06CALL0 0206.39TRUE00
2026-04-17104.44CALL4 2190.78TRUE4.440
2026-04-17114.05CALL0 19147.12TRUE00
2026-04-17123.4CALL0 12109.22TRUE00
2026-04-17132.1CALL0 19103.65TRUE00
2026-04-17142.34CALL0 61100.66TRUE00
2026-04-17150.75CALL7 9365.49FALSE-0.33-0.31
2026-04-17160.4CALL50 1150461.95FALSE-0.25-0.38
2026-04-17170.22CALL44 50862.21FALSE-0.03-0.12
2026-04-17180.15CALL16 1134466.95FALSE00
2026-04-17190.1CALL0 122133.6FALSE00
2026-04-17200.12CALL0 128125.21FALSE00
2026-04-17210.25CALL0 92140.47FALSE00
2026-04-17220.31CALL0 126155.02FALSE00
2026-04-17230.02CALL0 30177.57FALSE00
2026-04-17240.31CALL0 66141.83FALSE00
2026-04-17251.15CALL0 32211.93FALSE00
2026-04-17270.34CALL0 1244.04FALSE00
2026-04-17300.32CALL0 1249.1FALSE00
2026-04-17350.05CALL0 1359.59FALSE00
2026-04-1750PUT0 0479.13FALSE00
2026-04-1780PUT0 0274.64FALSE00
2026-04-1790PUT0 0211.56FALSE00
2026-04-17100.5PUT0 1000177.95FALSE00
2026-04-17110.37PUT0 34165.31FALSE00
2026-04-17120.3PUT0 528117.76FALSE00
2026-04-17130.38PUT0 163062.44FALSE00
2026-04-17140.86PUT34 72567.02FALSE0.110.15
2026-04-17151.32PUT9 32760.68TRUE0.120.1
2026-04-17161.65PUT21 7948.39TRUE1.650
2026-04-17172.82PUT21 9957.55TRUE0.30.12
2026-04-17183.46PUT7 270TRUE3.460
2026-04-17194.21PUT5 110TRUE4.210
2026-04-17202.5PUT0 80TRUE00
2026-04-17210PUT0 00TRUE00
2026-04-17220PUT0 00TRUE00
2026-04-17238.5PUT1 10TRUE8.50
2026-04-17240PUT0 00TRUE00
2026-04-17256.6PUT0 50TRUE00
2026-04-17270PUT0 00TRUE00
2026-04-17300PUT0 00TRUE00
2026-04-17350PUT0 00TRUE00
2026-05-1550CALL0 0163.35TRUE00
2026-05-1580CALL0 0119.19TRUE00
2026-05-1590CALL0 0138.73TRUE00
2026-05-15105.18CALL0 76111.99TRUE00
2026-05-15115CALL0 294.87TRUE00
2026-05-15120CALL0 098.35TRUE00
2026-05-15132.64CALL0 14101.77TRUE00
2026-05-15140CALL0 099.86TRUE00
2026-05-15151.5CALL1 4379.04FALSE-0.29-0.16
2026-05-15161.4CALL0 17184.56FALSE00
2026-05-15170.9CALL0 4966.31FALSE00
2026-05-15180.5CALL3 19969.93FALSE0.50
2026-05-15190.57CALL9 79883.13FALSE0.060.12
2026-05-15200.25CALL4 263469.9FALSE-0.05-0.17
2026-05-15210.37CALL0 25109.78FALSE00
2026-05-15220.66CALL0 54138.84FALSE00
2026-05-15230.15CALL0 17146.03FALSE00
2026-05-15241.65CALL0 35152.74FALSE00
2026-05-15250.04CALL0 20148.05FALSE00
2026-05-15300.65CALL0 2161.69FALSE00
2026-05-15350.21CALL0 2206.66FALSE00
2026-05-1550PUT0 0282.3FALSE00
2026-05-1580PUT0 0193.06FALSE00
2026-05-1590PUT0 0180.33FALSE00
2026-05-15100PUT0 0139.66FALSE00
2026-05-15110.15PUT0 44103.61FALSE00
2026-05-15120.59PUT62 164273.59FALSE0.590
2026-05-15130.95PUT20 177873.51FALSE0.950
2026-05-15141.34PUT14 30570FALSE0.10.08
2026-05-15151.75PUT0 31261.96TRUE00
2026-05-15162.35PUT57 19160.07TRUE-0.06-0.02
2026-05-15173.27PUT21 6568.59TRUE3.270
2026-05-15183.84PUT7 2152.94TRUE3.840
2026-05-15194.49PUT5 2162.01TRUE4.490
2026-05-15203.2PUT0 70TRUE00
2026-05-15213.7PUT0 10TRUE00
2026-05-15224.2PUT0 20TRUE00
2026-05-15235PUT0 10TRUE00
2026-05-15240PUT0 00TRUE00
2026-05-15250PUT0 078.61TRUE00
2026-05-15300PUT0 00TRUE00
2026-05-15350PUT0 0116.81TRUE00
2026-06-18512.03CALL0 15106.47TRUE00
2026-06-1898.19CALL0 79114.3TRUE00
2026-06-18100CALL0 095.64TRUE00
2026-06-18114.88CALL0 1083.75TRUE00
2026-06-18126.7CALL0 1287.24TRUE00
2026-06-18132.7CALL4 6571.17TRUE-0.5-0.16
2026-06-18142.65CALL0 969.43TRUE00
2026-06-18152.19CALL0 9573.86FALSE00
2026-06-18162.25CALL0 123141.66FALSE00
2026-06-18171.99CALL0 7136.03FALSE00
2026-06-18180.9CALL0 124179.76FALSE00
2026-06-18190.53CALL23 4363.08FALSE-0.09-0.15
2026-06-18200.5CALL0 67257.6FALSE00
2026-06-18220.27CALL0 23479.6FALSE00
2026-06-18250.8CALL0 25111.47FALSE00
2026-06-18270.7CALL0 409110.35FALSE00
2026-06-18300.37CALL0 15136.51FALSE00
2026-06-18350.1CALL0 30152.71FALSE00
2026-06-1850PUT0 0265.18FALSE00
2026-06-1890.46PUT0 8142.37FALSE00
2026-06-18100PUT0 0121.27FALSE00
2026-06-18110.45PUT0 3068.48FALSE00
2026-06-18120.8PUT5 17168.24FALSE0.110.16
2026-06-18131.15PUT3 12666.44FALSE0.160.16
2026-06-18141.63PUT6 7266.39FALSE1.630
2026-06-18151.8PUT0 20666.48TRUE00
2026-06-18163.1PUT0 27055.74TRUE00
2026-06-18172.7PUT0 3573.56TRUE00
2026-06-18183.5PUT0 2451.86TRUE00
2026-06-18192.65PUT0 1038.28TRUE00
2026-06-18205.5PUT0 340TRUE00
2026-06-18220PUT0 00TRUE00
2026-06-18259PUT0 065.7TRUE00
2026-06-18270PUT0 00TRUE00
2026-06-18300PUT0 00TRUE00
2026-06-18350PUT0 097.5TRUE00
2026-08-21100CALL0 096.74TRUE00
2026-08-21116.6CALL0 383.01TRUE00
2026-08-21120CALL0 073.37TRUE00
2026-08-21134.84CALL0 280.16TRUE00
2026-08-21140CALL0 075.8TRUE00
2026-08-21153.1CALL0 10182.68FALSE00
2026-08-21162.6CALL0 1573.04FALSE00
2026-08-21171.69CALL3 25968.77FALSE0.140.09
2026-08-21181.8CALL0 9969.27FALSE00
2026-08-21192.12CALL0 770.57FALSE00
2026-08-21200.8CALL1 19761.68FALSE0.80
2026-08-21210.9CALL0 1999.25FALSE00
2026-08-21220.8CALL0 2192.73FALSE00
2026-08-21230.35CALL12 257.56FALSE0.350
2026-08-21240.85CALL0 296.85FALSE00
2026-08-21250.94CALL0 9100.7FALSE00
2026-08-21260CALL0 0110.43FALSE00
2026-08-21270.12CALL0 6113.9FALSE00
2026-08-21300.5CALL0 6110.48FALSE00
2026-08-21100.5PUT0 9978.53FALSE00
2026-08-21110.85PUT0 22261.33FALSE00
2026-08-21121.1PUT1 1263.21FALSE-0.05-0.04
2026-08-21131.5PUT3 2662.26FALSE0.030.02
2026-08-21142.05PUT1 563.57FALSE2.050
2026-08-21152PUT0 654.7TRUE00
2026-08-21162.7PUT0 1149.55TRUE00
2026-08-21173.3PUT0 2846.28TRUE00
2026-08-21184.14PUT0 646.83TRUE00
2026-08-21194.7PUT0 147.38TRUE00
2026-08-21204.6PUT0 143.59TRUE00
2026-08-21216.8PUT0 140.6TRUE00
2026-08-21220PUT0 044.42TRUE00
2026-08-21230PUT0 00TRUE00
2026-08-21249.4PUT0 70TRUE00
2026-08-21250PUT0 00TRUE00
2026-08-21260PUT0 00TRUE00
2026-08-21270PUT0 060.69TRUE00
2026-08-21300PUT0 00TRUE00
2026-11-2080CALL0 093.24TRUE00
2026-11-2090CALL0 086.52TRUE00
2026-11-20100CALL0 073.12TRUE00
2026-11-20110CALL0 072.79TRUE00
2026-11-20120CALL0 068.37TRUE00
2026-11-20130CALL0 074.83TRUE00
2026-11-20140CALL0 070.75TRUE00
2026-11-20150CALL0 068.76FALSE00
2026-11-20160CALL0 069.72FALSE00
2026-11-20170CALL0 065FALSE00
2026-11-20180CALL0 064.86FALSE00
2026-11-20190CALL0 065.1FALSE00
2026-11-20200CALL0 0101.56FALSE00
2026-11-20210CALL0 0105.88FALSE00
2026-11-20220CALL0 0100.23FALSE00
2026-11-20230CALL0 0100.7FALSE00
2026-11-20240CALL0 099.8FALSE00
2026-11-2080PUT0 0119.97FALSE00
2026-11-2090PUT0 0115.97FALSE00
2026-11-20100PUT0 0130.23FALSE00
2026-11-20110PUT0 080.68FALSE00
2026-11-20120PUT0 069.54FALSE00
2026-11-20130PUT0 075.12FALSE00
2026-11-20142.36PUT20 058.58FALSE2.360
2026-11-20150PUT0 065.36TRUE00
2026-11-20160PUT0 052.69TRUE00
2026-11-20170PUT0 055.19TRUE00
2026-11-20180PUT0 054.53TRUE00
2026-11-20190PUT0 057.53TRUE00
2026-11-20200PUT0 058.75TRUE00
2026-11-20210PUT0 052.62TRUE00
2026-11-20220PUT0 053.46TRUE00
2026-11-20230PUT0 047.64TRUE00
2026-11-20240PUT0 00TRUE00
2027-01-15311.92CALL0 33110.49TRUE00
2027-01-15510.77CALL0 1290.37TRUE00
2027-01-1589.72CALL0 1988.73TRUE00
2027-01-15106.7CALL1 43495.44TRUE6.70
2027-01-15134.9CALL0 12268.41TRUE00
2027-01-15153.35CALL100 87967.39FALSE-0.05-0.01
2027-01-15172.63CALL1 59865.91FALSE2.630
2027-01-15201.67CALL7 174161.32FALSE00
2027-01-15221.2CALL0 52165.14FALSE00
2027-01-15250.9CALL5 73560.59FALSE0.90
2027-01-15270.85CALL0 349656.68FALSE00
2027-01-15300.6CALL0 57182.65FALSE00
2027-01-15320.55CALL0 22108.93FALSE00
2027-01-15350.5CALL0 167112.44FALSE00
2027-01-15370.3CALL0 4114.75FALSE00
2027-01-1530PUT0 00FALSE00
2027-01-1550PUT0 50FALSE00
2027-01-1580.48PUT0 9696.17FALSE00
2027-01-15101.21PUT0 45121.08FALSE00
2027-01-15131.77PUT0 109548.25FALSE00
2027-01-15152.39PUT0 20947.41TRUE00
2027-01-15173.1PUT0 9873.13TRUE00
2027-01-15206PUT0 4458.46TRUE00
2027-01-15227.8PUT0 19643.42TRUE00
2027-01-152510.6PUT0 5754.02TRUE00
2027-01-15270PUT0 30TRUE00
2027-01-15300PUT0 061.99TRUE00
2027-01-15320PUT0 00TRUE00
2027-01-15350PUT0 00TRUE00
2027-01-153717.31PUT0 00TRUE00
2028-01-21313CALL0 510TRUE00
2028-01-2150CALL0 078.72TRUE00
2028-01-2188.63CALL0 371.42TRUE00
2028-01-21107.5CALL1 6276.07TRUE7.50
2028-01-21136.7CALL0 9675.95TRUE00
2028-01-21156.3CALL0 15554.72FALSE00
2028-01-21175.35CALL0 5873.38FALSE00
2028-01-21204.08CALL20 22370.37FALSE0.180.05
2028-01-21223.32CALL0 6959.21FALSE00
2028-01-21254CALL0 25493.97FALSE00
2028-01-21272.84CALL0 1565.71FALSE00
2028-01-21302.5CALL0 28102.35FALSE00
2028-01-21352.1CALL0 11108.96FALSE00
2028-01-2130PUT0 00FALSE00
2028-01-2150PUT0 00FALSE00
2028-01-2181.07PUT0 2112.45FALSE00
2028-01-21101.83PUT0 264.66FALSE00
2028-01-21132.15PUT0 257.8FALSE00
2028-01-21154.23PUT0 1659.08TRUE00
2028-01-21175.5PUT0 12262.88TRUE00
2028-01-21200PUT0 057.92TRUE00
2028-01-21220PUT0 056.46TRUE00
2028-01-212510.8PUT0 253.05TRUE00
2028-01-21270PUT0 057.31TRUE00
2028-01-21300PUT0 053.86TRUE00
2028-01-21350PUT0 061.64TRUE00

Latest ADMA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST38$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST36$1.905
Jun 13, 2022 7:59 PM EST100$1.9

ADMA Biologics, Inc (ADMA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2019-10-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2019-06-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm
2019-05-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm
2019-04-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm
2019-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm
2019-05-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm
2019-06-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm
2019-07-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm
2019-07-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm
2019-10-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm
2020-02-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm
2020-04-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm
2020-08-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm
2020-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm
2019-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm
2018-09-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm
2019-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm
2020-02-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm

ADMA Biologics, Inc (ADMA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 213%
Institutional Ownership: 5451%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-17Jerrold B GrossmanDirectorBuy12,000.004.0048,000.00110,007.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,000,000.004.0016,000,000.0011,521,102.00https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.50132,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-28Jerrold B GrossmanDirectorBuy7,500.00140,364.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy200.002.87574.00140,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.8914,450.00145,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.9014,475.00150,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy5,000.002.5612,800.00155,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy300.002.62786.00155,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-02-11PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,563,700.003.5015,972,950.0016,084,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-09-10Jerrold B GrossmanDirectorBuy5,000.002.2211,100.00160,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-03-19PERCEPTIVE ADVISORS LLC10% Share HolderBuy500,000.002.101,050,000.0016,584,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2020-02-28Adam S GrossmanPresident and CEOBuy100,000.00166,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy10.003.0630.60166,108.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,990.003.079,179.30169,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,000.003.046,080.00171,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-11Adam S GrossmanPresident and CEOBuy1,000.002.972,970.00172,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-09-08Adam S GrossmanPresident and CEOBuy4,000.002.248,959.60176,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2019-05-17James MondEVP, CSO and CMOBuy4,500.004.0018,000.0017,889.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2020-08-13MARTHA J DEMSKIDirectorBuy2,000.002.885,760.002,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-02-11James MondCSO and CMOBuy4,285.003.5014,997.5022,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.5022,857.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2019-05-17BRIAN LENZEVP, CFOBuy5,000.004.0020,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2020-02-11BRIAN LENZEVP, CFOBuy7,142.003.5024,997.0032,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy5,000.004.0020,000.0037,527.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-09-11MARTHA J DEMSKIDirectorBuy2,200.002.295,038.004,200.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2019-06-06Biotest Divestiture Trust10% Share HolderSell5,813,954.003.7521,802,327.504,295,580.00https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2020-02-28ERIC I RICHMANDirectorBuy7,500.0044,030.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2019-05-17Lawrence P. GuiheenDirectorBuy25,000.004.00100,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2020-02-28James MondEVP, CSO and CMOBuy40,000.0062,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy28,571.003.5099,998.5066,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-08-10James MondEVP, CSO and CMOBuy5,000.002.8814,400.0067,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-10James MondEVP, CSO and CMOBuy2,000.002.885,750.0069,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-02-11Lawrence P. GuiheenDirectorBuy20,000.003.5070,000.0070,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-28BRIAN LENZEVP, CFOBuy40,000.0072,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-09-08James MondEVP, CSO and CMOBuy4,000.002.208,800.0073,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-02-28Bryant FongDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-02-28DOV A MD GOLDSTEINDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-02-28STEVE ELMSDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-08-11BRIAN LENZEVP, CFOBuy4,000.002.9711,860.0076,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-02-28Lawrence P. GuiheenDirectorBuy7,500.0077,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy25,000.004.00100,000.00821,301.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy57,143.003.50200,000.50878,444.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm